SCHEMBL7966017

SCHEMBL7966017

OC(CCOc1cccc2[nH]ccc12)N1CCC(c2cnc3ccccc3c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 20/20 0.46
SLC6A4 P31645 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966960 0.86 HTR1A (0.46) HTR1ASLC6A4
SCHEMBL7965634 0.84 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL7966018 0.83 HTR1A (0.68) HTR1ASLC6A4
SCHEMBL7965925 0.82 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL7953366 0.82 HTR1A (0.43) HTR1ASLC6A4
SCHEMBL7966021 0.82 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL7964956 0.82 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL8871724 0.77 HTR1A (0.46) HTR1ASLC6A4
Maleic Acid SCHEMBL7967346 0.75 RAB9A (0.42)
Fumaric Acid SCHEMBL7967350 0.75 RAB9A (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed